Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction

CONCLUSIONS: PCs serve as potential plasma biomarkers and help identify patients with HBVLD at risk of HCC who should be screened for early diagnosis and intervention.PMID:37672012 | DOI:10.1080/14737159.2023.2254884
Source: Expert Review of Molecular Diagnostics - Category: Laboratory Medicine Authors: Source Type: research